辉瑞新冠药医保没谈成，这只A股开盘跌超8%！将生产仿制药？公司回应

七印授权

3990AMIDTXM8SIR9MNP4SE9QBHSY08DBGVEBGIYRI7MI3B6EO1

2023-01-22 19:58:09

article

CA9D29EC96831C64301495BA0C5E83BC3D6D941936061C2A3575CE75F7D9C53E

zh-CN

4923CFCD2C90249044AAB7420DC1644D9EAE543A

13998406

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

0b0c3dd6c49882594b78c76a01fe1d71dd9c97224c7107a1be25321a59d2cb803e1f0355a735b7f5ade693e4532bfb7a4ea9be963bc106c8a44d963d86ecef2d1b

{"parameters":{"adaptation":"n","price":"300000"},"type":"cm"}

yuanben_63cd9551bc8014.18058382

原本认证

https://www.yuanben.io/article/0d5a1d78-00f9-43fc-84a5-054bb2d05882

{"author":"每日经济新闻","authorization_pub_key":"03040cbbeae1adf91c3efd7306d09c6005403a041f9b7405dac489d4f8126fef8c"}